Although these comparisons did not reach statistical significance, the uniform direction of the hazard ratios (HR > 1) suggests that the intensive chemotherapy schedule may mitigate the efficacy gap between chemotherapy and immunotherapy.
← all excerpts
The efficacy and safety of interval and post-reTURBT intravesical therapy for bladder cancer.
1
—
—